ClinicalTrials.Veeva
Menu

Find clinical trials for Melanoma in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Renal Cell Carcinoma
Squamous Cell Carcinoma
Lung Cancer

Melanoma trials near Salt Lake City, UT, USA:

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

therapy per local standard of care (SoC), best supportive care (BSC)) on protocol survivor follow up) in patients with advanced non-ocular melanoma...

Enrolling
Advanced Melanoma
Drug: Tebentafusp with Pembrolizumab
Drug: Tebentafusp

Phase 2, Phase 3

Immunocore
Immunocore

Salt Lake City, Utah, United States and 70 other locations

binimetinib, and pembrolizumab) given together for the treatment of melanoma that:* is advanced or metastatic (spread to other parts of the ...

Active, not recruiting
Melanoma
Drug: Binimetinib
Drug: Encorafenib

Phase 3

Pfizer
Pfizer

Salt Lake City, Utah, United States and 227 other locations

efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melanoma...

Enrolling
Ocular Melanoma
Choroidal Melanoma
Device: Suprachoroidal Microinjector
Drug: Sham Treatment

Phase 3

Aura Biosciences
Aura Biosciences

Salt Lake City, Utah, United States of America and 37 other locations

(Spartalizumab (PDR001)), a BRAF inhibitor (dabrafenib) and a MEK inhibitor (trametinib) in unresectable or metastatic BRAF V600 mutant melanoma...

Active, not recruiting
Melanoma
Drug: Trametinib
Drug: Dabrafenib

Phase 3

Novartis
Novartis

Salt Lake City, Utah, United States and 178 other locations

This is an open-label, 3-arm, fixed-sequence study to evaluate the effect of single and multiple oral doses of encorafenib in combination with binime...

Active, not recruiting
Metastatic Melanoma
Advanced Solid Tumors
Drug: rosuvastatin
Drug: dextromethorphan

Phase 1

Pfizer
Pfizer

West Valley City, Utah, United States and 27 other locations

Locations recently updated

not worse than nivolumab + relatlimab FDC intravenous (IV) administration in participants with previously untreated metastatic or unresectable melanoma...

Enrolling
Melanoma
Drug: Nivolumab + Relatlimab
Drug: rHuPH20

Phase 3

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Murray, Utah, United States and 189 other locations

defactinib in combination with avutometinib in brain metastases from melanoma, and to define the potential role of the combination with muta...

Enrolling
Melanoma
Drug: Defactinib
Drug: Avutometinib

Phase 1, Phase 2

Utah System of Higher Education (USHE)
Utah System of Higher Education (USHE)

Salt Lake City, Utah, United States

be those with pathological diagnosis of unresectable or metastatic melanoma who are progressing or have progressed on either pembrolizumab o...

Active, not recruiting
Stage III/IV Melanoma
Biological: Pembrolizumab
Biological: tavokinogene telseplasmid

Phase 2

OncoSec Medical

Salt Lake City, Utah, United States and 32 other locations

UV1 is a therapeutic cancer vaccine that has been explored in prostate and lung cancers, and in combination with ipilimumab in malignant melanoma...

Active, not recruiting
Malignant Melanoma
Drug: UV1
Drug: GM-CSF

Phase 1

Ultimovacs

Salt Lake City, Utah, United States and 3 other locations

trial, 20 adult subjects (≥ 18 years of age) with advanced non-melanoma skin cancers will receive a fixed dose of 0.1 mg of IFx-Hu2.0 intral...

Active, not recruiting
Non-Melanoma Skin Cancers
Cutaneous Squamous Cell Carcinoma
Biological: IFx-Hu2.0

Phase 1

TuHURA Biosciences

Salt Lake City, Utah, United States and 3 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems